A Comparison of Naropin and Ketorolac for Postoperative Analgesia After Total Knee Arthroplasty
Information source: University of Aarhus
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Postoperative Pain
Intervention: Ketorolac (Drug); Saline (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: University of Aarhus Official(s) and/or principal investigator(s): Kjels Søballe, Professor, Principal Investigator, Affiliation: Aarhus University Hospital
Summary
The purpose of this study is to determine wether ketorolac is effective in the treatment of
postoperative pain after total knee arthroplasty
Clinical Details
Official title: Local Infiltration Analgesia for Total Knee Arthroplasty: Should Ketorolac be Added
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Morphine Consumption
Secondary outcome: Time to First i.v. Patient Controlled Analgesia (PCA) Morphine RequestPain Intensity Scores During Walking Home Readiness Length of Hospital Stay Pain Intensity During Daily Activity
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Total knee arthroplasty
- Age > 18
- Tolerance for study drugs
- Written informed consent
Exclusion Criteria:
-
Locations and Contacts
Aarhus University, Aarhus 8000, Denmark
Additional Information
Starting date: May 2009
Last updated: January 22, 2014
|